BridgeMD
Tests treatment safety and results for Episodic Migraine
Official title A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
ClinicalTrials.gov ID: NCT07018700
What this study is testing
What is Xeomin?
Xeomin is an investigational medicine, given as a monthly injectable medicine, being studied as a potential treatment for episodic migraine.
Also referred to as IncobotulinumtoxinA, NT 201.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- In this clinical trial, participants with episodic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine days with Xeomin injections compared to Placebo injections.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant has a diagnosis of EM with or without aura according to current International Classification of Headache Disorders (Edition 3 and Edition...
- Participant age \< 50 years at the time of migraine onset;
- Participant meeting the following headache and migraine day criteria in each of the 3 months prior to screening: history of ≤ 14 headache days per...
- During the last 28 days of the screening period, participant experiencing: ≤ 14 headache days and 6 to 14 migraine days that qualify as such per the...
You likely can't join if
- Diagnosis of chronic migraine;
- Diagnosis of other primary headache types, except tension-type headache, which is permitted;
- Diagnosis of aura without headache, migraine with brainstem aura, hemicrania continua, hypnic headache, hemiplegic migraine, retinal migraine...
- Diagnosis of secondary headache types, except medication overuse headache, which is permitted;
- Currently taking \> 1 prescribed drug for the preventive treatment of migraine;
- Discontinuation of anti-calcitonin gene-related peptide (CGRP) / anti-CGRP receptor monoclonal antibody treatment less than 5 months prior to...
The study team makes the final eligibility decision.
Where it's taking place
- Chandler, Arizona, United States
- Phoenix, Arizona, United States
- Little Rock, Arkansas, United States
- Lancaster, California, United States
- Los Angeles, California, United States
- Thousand Oaks, California, United States
- Torrance, California, United States
- New Haven, Connecticut, United States
- Stamford, Connecticut, United States
- Gulf Breeze, Florida, United States
- Homestead, Florida, United States
- Jacksonville, Florida, United States
- Lakeland, Florida, United States
- Miami, Florida, United States
- West Palm Beach, Florida, United States
- Decatur, Georgia, United States
- Honolulu, Hawaii, United States
- Overland Park, Kansas, United States
- Chalmette, Louisiana, United States
- New Orleans, Louisiana, United States
+ 71 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chandler, Arizona, United States; Phoenix, Arizona, United States; Little Rock, Arkansas, United States; Lancaster, California, United States; Los Angeles, California, United States; Thousand Oaks, California, United States and 85 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.